-- 根據澳新銀行（ANZ）週三發布的報告，紐西蘭第一季失業率預計將維持在5.4%的穩定水平，略低於先前預測的5.5%。 報告指出，澳新銀行將季度就業成長預期上調0.1個百分點至0.3%，3月就業成長動能似乎比預期更為強勁。 即將公佈的受薪工時和實際工時數據或許能反映出第一季GDP環比成長0.8%預期面臨的風險，但由於勞動力市場通常是最後一個對經濟環境變化做出反應的行業，因此近期石油危機的影響可能尚未顯現。 預計第一季勞動力市場數據顯示，市場擁有足夠的過剩產能，足以緩衝近期石油危機的影響，降低勞動力成本在短期內推高通膨的風險。
Related Articles
Asia
JCET's Q1 Profit Jumps 43%, Revenue Slips 2%
JCET's (SHA:600584) net profit attributable to shareholders in the first quarter jumped 43% to 290.3 million yuan from 203.4 million yuan a year earlier, according to a Shanghai bourse filing on Wednesday.Earnings per share rose 45% year on year to 0.16 yuan from 0.11 yuan.Operating revenue slipped 1.8% to 9.17 billion yuan from 9.34 billion yuan in the preceding year.The shares of the Chinese integrated circuit manufacturer dropped less than 3% during midday trade.
$SHA:600584
Asia
Update: G8 Education to Suspend Operation of Around 40 Centers, Shares Reach 16-Year Low
(Updates to add the stock movement in the sixth paragraph)G8 Education (ASX:GEM) plans to suspend the operation of around 40 of its centers as a result of an assessment of its network, according to a Wednesday Australian bourse filing.It will transition customers to one of the nearby centers and, where possible, redeploy team members. The firm will then consider longer-term options for those centers, including lease surrender, divestment, or other alternatives.The firm will also reorganize its support office structure and reduce its cost base.Its current spot occupancy as of April 24 came in at 56.4%, down 7% year-over-year, while year-to-date occupancy was 56.1%, down 7.9% versus the prior corresponding period.Occupancy across the early childhood education and care sector is lower compared to previous years due to sustained affordability pressures, falling birth rates, increased long-day care supply, and confidence impacted by serious child safety incidents, the filing noted.Its shares fell 25% in recent trading on Wednesday, earlier reaching a 16-year low.
$ASX:GEM
Asia
Fosun Pharmaceutical Reports 14% Higher Profit in Q1
Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196) logged a 14% rise in its attributable profit for the first quarter of 2026 to 870.8 million yuan from 764.8 million yuan a year earlier, according to a Hong Kong bourse filing Tuesday.The pharmaceutical company's Hong Kong shares fell nearly 2% in late morning trade Wednesday.Earnings per share were 0.33 yuan, compared with 0.29 yuan in the prior year.Operating revenue gained nearly 7% to 10.1 billion yuan, figures showed.
$HKG:2196$SHA:600196